agilon health, inc. (NYSE:AGL) Sees Significant Growth in Short Interest

agilon health, inc. (NYSE:AGL) was the recipient of a large growth in short interest in November. As of November 30th, there was short interest totalling 31,940,000 shares, a growth of 5.1% from the November 15th total of 30,390,000 shares. Based on an average daily volume of 4,590,000 shares, the days-to-cover ratio is currently 7.0 days. Currently, 10.5% of the company’s stock are sold short.

Wall Street Analysts Forecast Growth

AGL has been the subject of several research reports. Barclays reduced their target price on agilon health from $5.00 to $2.00 and set an “underweight” rating for the company in a report on Monday, November 11th. Bank of America downgraded agilon health from a “buy” rating to an “underperform” rating and set a $3.00 target price for the company. in a report on Wednesday, October 2nd. TD Cowen reduced their target price on agilon health from $6.00 to $2.00 and set a “hold” rating for the company in a report on Monday, November 11th. Evercore ISI dropped their price target on agilon health from $7.00 to $4.00 and set an “in-line” rating on the stock in a research report on Tuesday, October 8th. Finally, Citigroup dropped their price target on agilon health from $2.50 to $1.75 and set a “sell” rating on the stock in a research report on Wednesday, November 13th. Three investment analysts have rated the stock with a sell rating, sixteen have issued a hold rating and two have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average target price of $4.28.

agilon health Price Performance

Shares of AGL traded down $0.19 on Tuesday, reaching $2.01. The stock had a trading volume of 3,411,171 shares, compared to its average volume of 4,855,191. The firm has a market capitalization of $826.10 million, a PE ratio of -2.13 and a beta of 0.51. The company has a quick ratio of 1.29, a current ratio of 1.29 and a debt-to-equity ratio of 0.06. The firm has a 50-day moving average of $2.40 and a 200 day moving average of $4.32. agilon health has a twelve month low of $1.50 and a twelve month high of $13.45.

agilon health (NYSE:AGL) last released its quarterly earnings results on Thursday, November 7th. The company reported ($0.29) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.10) by ($0.19). The firm had revenue of $1.45 billion during the quarter, compared to analyst estimates of $1.47 billion. agilon health had a negative return on equity of 47.84% and a negative net margin of 6.88%. During the same quarter in the prior year, the company earned ($0.06) EPS. Sell-side analysts expect that agilon health will post -0.52 EPS for the current year.

Insider Buying and Selling

In other agilon health news, Director Diana Mckenzie purchased 12,500 shares of the firm’s stock in a transaction on Monday, November 25th. The stock was bought at an average cost of $2.28 per share, with a total value of $28,500.00. Following the acquisition, the director now directly owns 51,319 shares of the company’s stock, valued at approximately $117,007.32. This represents a 32.20 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director John William Wulf purchased 45,000 shares of the firm’s stock in a transaction on Thursday, December 5th. The shares were acquired at an average cost of $2.18 per share, with a total value of $98,100.00. Following the completion of the acquisition, the director now directly owns 206,133 shares in the company, valued at $449,369.94. The trade was a 27.93 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders purchased 90,000 shares of company stock valued at $198,100 in the last three months. 3.20% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On agilon health

A number of institutional investors and hedge funds have recently modified their holdings of AGL. Virtu Financial LLC purchased a new stake in agilon health in the 3rd quarter valued at approximately $120,000. Geode Capital Management LLC lifted its stake in agilon health by 1.2% in the 3rd quarter. Geode Capital Management LLC now owns 6,893,517 shares of the company’s stock valued at $27,097,000 after buying an additional 84,889 shares in the last quarter. Barclays PLC lifted its stake in agilon health by 21.2% in the 3rd quarter. Barclays PLC now owns 1,228,952 shares of the company’s stock valued at $4,830,000 after buying an additional 214,830 shares in the last quarter. XTX Topco Ltd lifted its stake in agilon health by 271.1% in the 3rd quarter. XTX Topco Ltd now owns 119,747 shares of the company’s stock valued at $471,000 after buying an additional 87,481 shares in the last quarter. Finally, State Street Corp lifted its stake in agilon health by 3.0% in the 3rd quarter. State Street Corp now owns 7,449,706 shares of the company’s stock valued at $29,277,000 after buying an additional 215,733 shares in the last quarter.

About agilon health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.